Download File

Image Modality: Illustration Table Figure

Description:

AHA 2022 Presentation Slides | PRECISION: Sustained Blood Pressure Lowering Effect With the Dual Endothelin Receptor Antagonist Aprocitentan in Resistant Hypertension: Results From a Randomized, Controlled Study Including a Withdrawal Phase

Date: November 06, 2022    

Clinical Topics: Prevention, Statins, Hypertension

Keywords: AHA Annual Scientific Sessions, AHA22Slides, Blood Pressure, Endothelin Receptor Antagonists, Hypertension, Sulfonamides